This suggests that intranasal insulin administration can be a simple and convenient strategy for the therapy of neurodegenerative disorders such as Alzheimer’s disease which are also accompanied by the impairment of insulin signaling. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.